Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with idiopathic Parkinson's disease (a specific form of Parkinson's not caused by another condition) confirmed by a neurologist
- People in Hoehn & Yahr stages I, II, or III (these are early to mid stages of Parkinson's disease — confirm with trial site if unsure which stage applies)
- People with no cognitive difficulties, or only mild to moderate cognitive difficulties
- People with or without symptoms of depression
- People who are able to walk on their own without assistance
- People whose Parkinson's medication type and dose has not changed in the three months before the study begins
- People who are able to understand and follow the instructions given during the study
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another neurological condition or a musculoskeletal (bone, joint, or muscle) condition alongside their Parkinson's disease
- People with a history of injury or surgery involving the legs or brain
- People who have vision or hearing problems that could affect their performance on thinking and memory tests
- People who have been clinically diagnosed with a major neurocognitive disorder (a significant decline in memory and thinking abilities)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Self-efficacy (The Latin Spanish version of the Self-Efficacy to Manage Chronic Disease for the Chilean population ); Self-efficacy (General Self-Efficacy Scale); Unified Parkinson's Disease Rating Scale (revised version); Balance; Gait (walking speed); Cognitive function; Brain activity of the Prefrontal cortex; Dual task cost; Difficulties associated with Parkinson's disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.